FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the release of the ...
Primerdesign (part of the Novacyt Group), a company focused on the design, manufacture, validation and supply of nucleic acid ...
Jeff Borgia, Ph.D. is the Director of the Rush Cancer Center Biorepository, where he oversees the collection and annotation of patient specimens in support of ongoing translational research projects ...
SAN DIEGO--(BUSINESS WIRE)--PhenoVista Biosciences, a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay services based in San Diego, ...
Creative Biolabs, a global leader in integrated biotechnology solutions, today announced the strategic expansion of its ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a series of enhancements for its QIAcuity series of digital PCR (dPCR) ...
First in human (FIH) clinical trials of bispecific immunostimulatory antibodies commonly require a low starting dose based on a minimum anticipated biological effect level (MABEL) approach. To ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
Precision medicine is driven by advances in omics technologies that facilitate identification of mutations and the presence or absence of certain molecular targets, which, in turn, enables streamlined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results